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Abstract
Background: Knowledge of differences in the cellular physiology of malignant and non-malignant
cells is a prerequisite for the development of cancer treatments that effectively kill cancer without
damaging normal cells. Calcium is a ubiquitous signal molecule that is involved in the control of
proliferation and apoptosis. We aimed to investigate if the endoplasmic reticulum (ER) Ca2+-
homeostasis is different in lung cancer and normal human bronchial epithelial (NHBE) cells.
Methods: The intracellular Ca2+-signaling was investigated using fluorescence microscopy and the
expression of Ca2+-regulating proteins was assessed using Western Blot analysis.
Results: In a Small Cell Lung Cancer (H1339) and an Adeno Carcinoma Lung Cancer (HCC) cell
line but not in a Squamous Cell Lung Cancer (EPLC) and a Large Cell Lung Cancer (LCLC) cell line
the ER Ca2+-content was reduced compared to NHBE. The reduced Ca2+-content correlated with
a reduced expression of SERCA 2 pumping calcium into the ER, an increased expression of IP3R
releasing calcium from the ER, and a reduced expression of calreticulin buffering calcium within the
ER. Lowering the ER Ca2+-content with CPA led to increased proliferation NHBE and lung cancer
cells.
Conclusion: The significant differences in Ca2+-homeostasis between lung cancer and NHBE cells
could represent a new target for cancer treatments.
Background
Lung cancer is the leading cause of cancer death in the
industrial nations [1]. Despite recent advances, therapeu-
tic regimens support quality of life but frequently fail to
increase long term survival. One of the main reasons for
the failure of therapeutic regimens is the fact that cancer
cells originate from normal cells and therefore possess
similar characteristics. This means that anti-cancer thera-
pies inevitably affect the normal cell population and these
side effects often hinder more effective treatments. Thus,
knowledge of the differences in the cellular physiology
between malignant and non-malignant cells is crucial for
the development of more successful treatments.
Calcium is a ubiquitous signal molecule that is involved
in almost all cellular pathways [2,3]. Elevation of the cyto-
plasmic Ca2+-concentration ([Ca2+]c) can result either
from Ca2+-influx from the extracellular space or from
Ca2+-release from internal Ca2+-stores, primarily the ER.
Proteins involved in the Ca2+-release from the ER are the
inositol-1,4,5-trisphosphate receptor (IP3R) and the ryan-
odine receptor (RyR) (Figure 1). Sarco/endoplasmic retic-
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ulum Ca2+-ATPases (SERCA) force calcium against the
concentration gradient from the cytoplasm into the ER.
Within the ER, calcium is buffered by calreticulin [2,3].
Calcium is particularly important for the regulation of
proliferation and apoptosis and the imbalance of cell
growth and cell death finally leads to cancer. The aim of
this study was therefore to evaluate whether the ER Ca2+-
homeostasis is altered in lung cancer cell lines compared
to normal bronchial epithelium.
Methods
Materials
Cell culture reagents were obtained from Life Technolo-
gies (Eggenstein, Germany). Other reagents were bought
from Sigma-Aldrich (Deisenhofen, Germany) unless
stated otherwise. The human lung carcinoma cell lines
H1339 (Small Cell Lung Carcinoma), DMI 53 pI (Small
Cell Lung Carcinoma), LCLC-103H (Large Cell Lung Car-
cinoma), EPLC 272 (Squamous Cell Lung Carcinoma),
EPLC M1 (Squamous Cell Lung Carcinoma) and HCC
(Adeno-Carcinoma) were purchased from the German
Collection of Microorganisms and Cell Cultures (DSMZ,
Braunschweig, Germany). Primary normal human bron-
chial epithelial cells (NHBE) were purchased from Lonza
(Walkersville, MD, USA).
Ca2+-imaging
For quantification of changes in the [Ca2+]c, cells were
loaded for 30 min at 37°C with the calcium indicator dye
Fluor-4 AM (10 μM, Molecular Probes, Eugene, OR) in
supplemented Hanks Balanced Salt Solution (sHBSS)
containing 0.2% Pluronic (Pluronic F-127, Calbiochem,
La Jolla, CA). After loading, the cells were incubated for at
least 30 min in sHBSS to allow for complete dye deesteri-
fication and examined with a fluorescence microscope
(Axiovert 200 M, Carl Zeiss, Jena, Germany). Images were
recorded in time lapse (1 frame/sec) using a digital CCD
camera (AxioCam MRm, Carl Zeiss Vision, Munich, Ger-
many). For each image, regions of interest (ROIs) were
defined in single cells, and the average fluorescence inten-
sity of each ROI was measured. Final fluorescence values
were expressed as a fluorescence ratio (F/Fo) normalized
to the initial fluorescence (Fo). Each analysis was per-
formed using custom written macros in the image analysis
software "Scion".
Western Blot analysis
Protein expression was determined by immunoblotting
with protein extracts prepared with the Compartmental
Protein Extraction Kit according to the manufacturer's
instructions (Chemicon International, Hampshire,
United Kingdom). EGFR was used as control for plasma
membrane contamination, which was found to be low
with no differences between cell types. Protein concentra-
tions of the extracts were quantified using the Bradford
Protein Assay Kit (Bio-Rad, Munich, Germany). Proteins
were separated by SDS polyacrylamide gel electrophoresis
(SDS-PAGE) on a 6% separating and 4% stacking gel (for
SERCA 2), on a 4% separating and 3% stacking gel (for
IP3R and RyR) and on a 10% separating and 4% stacking
gel (for calreticulin) and transferred to nitrocellulose
membranes (Hybond ECL Membrane, Amersham Bio-
sciences, UK). After blocking for 2 hours in a 5% solution
of non-fat dried milk/TBST (TBS with 0.05% Tween 20),
the membranes were incubated overnight at 4°C with
specific antibodies (SERCA 2 Abcam 1:1000, Mouse anti-
Ryanodine Receptor Chemicon 1:500, Mouse anti-IP3
Receptor Chemicon 1:500, anti-Calreticulin antibody
Sigma-Aldrich 1:4000, Beta Actin Antibody (HRP) Load-
ing control Abcam 1:5000, SERCA1 ATPase antibody
[VE121G9] Abcam 1:500, SERCA3 ATPase antibody
Abcam 1:200). Sheep anti-mouse IgG horseradish peroxi-
dase linked whole antibodies (Amersham Biosciences,
UK, 1:1500) were used as secondary antibodies. β-actin
served as a loading control. Antibody complexes were vis-
ualized using Hyperfilm ECL chemiluminescence (Amer-
sham Biosciences, UK) and evaluated using the "Image-J"
analysis software.
Statistics
One-way ANOVA or "ANOVA repeated measurements"
(combined with pairwise multiple comparisons) were
performed using the "Sigma Stat" software (Jandel Scien-
tific, Chicago, IL). A P value of less than 0.05 was consid-
ered statistically significant.
Increase in the cytoplasmic Ca2+-concentration can be due to  Ca2+-influx from the extracellular space or due to Ca2+- release from the endoplasmic reticulum (ER) Figure 1
Increase in the cytoplasmic Ca2+-concentration can 
be due to Ca2+-influx from the extracellular space or 
due to Ca2+-release from the endoplasmic reticulum 
(ER). The equilibrium of the ER Ca2+-content is maintained 
by sarcoplasmic/endoplasmic reticulum Ca2+-ATPases 
(SERCA) pumping calcium into the ER and inositol-1,4,5-
phosphate- (IP3R) and ryanodine-receptors (RYR) releasing 
calcium out of the ER. Within the ER, calcium is mainly buff-
ered by calreticulin.
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Results
To investigate the role of Ca2+-influx in Ca2+-homeostasis
in lung cancer cells, NHBE (normal human bronchial epi-
thelial), H1339 (small cell lung carcinoma), HCC (adeno
carcinoma), EPLC 272 (squamous cell carcinoma) and
LCLC (large cell lung carcinoma) cells were exposed to 1
mM ATP in the presence and the absence of extracellular
calcium (PBS containing no calcium but 0.02% EGTA).
The resulting increase in the [Ca2+]c was quantified using
fluorescence microscopy. Baseline fluorescence values
were similar in all cell lines (data not shown). In NHBE,
H1339 and HCC cells, the ATP-induced Ca2+-increase was
comparable with and without external calcium suggesting
an insignificant role for Ca2+-influx (Figure 2). In EPLC
272 and LCLC cells, the ATP-induced Ca2+-increase was
lower in the absence of extracellular calcium.
Direct measurement of the ER Ca2+-concentration
([Ca2+]ER) is not reliably feasible. Therefore, we used an
indirect approach. SERCA were inhibited using 1 μM
cyclopiazonic acid (CPA) leading to a net Ca2+-efflux out
of the ER. The resulting increase in [Ca2+]c was used as an
estimate of the [Ca2+]ER [4]. In the lung cancer cell lines in
which Ca2+-influx contributed to the ATP-induced Ca2+-
increase (EPLC 272 and LCLC) the [Ca2+]ER was equal to
the [Ca2+]ER in NHBE (Figure 3A). In those lung cancer cell
lines in which the Ca2+-influx did not contribute to the
ATP-induced Ca2+-increase (H1339 and HCC) [Ca2+]ER
was lower than in NHBE. The SCLC line H1339 showed
the lowest [Ca2+]ER (Figure 3B).
Next, we investigated the expression of the proteins that
regulate the [Ca2+]ER. SERCA pump calcium from the cyto-
plasm into the ER. Three isoforms of SERCA of have been
identified so far and, of these, SERCA 2 has been reported
to be the most widely expressed [5]. Analyzing the SERCA
expression using Western Blot analysis, we found the iso-
forms SERCA 1 and 3 to be very weakly expressed (data
not shown), while SERCA 2 showed strong expression as
confirmed by immuno-fluorescence (Figure 4). Compar-
ing the expression of SERCA 2 in NHBE, H1339, and HCC
cells, we found lower levels of expression in the lung can-
cer cells with expression in H1339 cells being the lowest
(Figure 5).
Ca2+-release channels of the ER are RyR and IP3R. In
NHBE, H1339, and HCC cells, we found the expression
RyR to be hardly detectable at all (data not shown). In
contrast, IP3R showed substantial expression, which was
higher in the lung cancer cell lines, and the highest in
H1339 cells (Figure 6).
Within the ER, calcium is buffered by calreticulin. The
expression of calreticulin was reduced in H1339 and HCC
compared to NHBE cells with the lowest levels of expres-
sion being found in HCC cells (Figure 7).
In order to directly investigate the effect of a reduction of
the [Ca2+]ER on the cell number, we treated the cells with
CPA and assessed the cell number after 24 h. In these
experiments, we used an additional non-small cell lung
cancer cell line (EPLC M1, squamous cell carcinoma) and
an additional small cell lung cancer cell line (DMI 53 pI).
In both cell lines, the ATP-induced increase in [Ca2+]C was
independent from Ca2+-influx from the extracellular space
(data not shown). Treatment with CPA caused in NHBE
cells and all lung cancer cell lines an increase in cell
number compared with non-treated controls (Figure 8).
Discussion
In this study, we showed that the contribution of Ca2+-
influx from the extracellular space to intracellular Ca2+-
homeostasis varied between lung cancer cell lines. How-
ever, in those cell lines in which Ca2+-influx played a
minor role (H1339 and HCC) the ER Ca2+-content was
Cells were exposed to 1 mM ATP in the presence and the  absence of extracellular calcium Figure 2
Cells were exposed to 1 mM ATP in the presence 
and the absence of extracellular calcium. The resulting 
increase in the cytoplasmic Ca2+-concentration was quanti-
fied using fluorescence microscopy. For each cell line, the 
Ca2+-increase with external calcium was set to 100% (black 
columns) and the Ca2+-increase without external calcium 
(white columns) was expressed as percent of the increase 
with external calcium. In normal bronchial epithelial (NHBE), 
Small Cell Lung Cancer (H1339) and Adeno-Carcinoma 
(HCC) cells, the ATP-induced Ca2+-increase was independ-
ent of the presence of extracellular calcium suggesting a 
minor role for Ca2+-influx. In Squamous Cell Lung Carcinoma 
(EPLC) and Large Cell Lung Carcinoma (LCLC) cells, the 
ATP-induced Ca2+-increase was lower in the absence of 
extracellular calcium (n = 42 – 162 cells, * = P < 0.001 versus 
"with external calcium").
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reduced compared to NHBE cells. The reduced Ca2+-con-
tent in H1339 and HCC cells correlated with a reduced
expression of SERCA 2 pumping calcium into the ER, an
increased expression of IP3R releasing calcium from the
ER, and a reduced expression of calreticulin buffering cal-
cium within the ER. Reducing the ER Ca2+-content with
CPA for 24 h led to an increased cell number.
The origin of the various lung carcinomas is still contro-
versially being discussed. While squamous cell lung carci-
nomas are believed to origin from metaplastic bronchial
epithelium, many authors believe small cell lung carcino-
mas to origin from neuro-epithelial bodies. But, the origin
of large cell carcinomas and adeno carcinomas is less
clear. However, being forced to choose a "normal" tissue
to compare the malignant cell lines with, we decided to
use normal human bronchial epithelial cells as a reference
knowing that this choice constitutes a compromise.
SERCA is an ER transmembrane protein, consisting of a
single polypeptide chain folded into four major domains,
and is encoded by the genes ATP2A1-3 [5]. So far, 3 iso-
forms have been identified. As SERCA serves to maintain
the concentration gradient between the cytoplasm and the
ER by pumping calcium into the ER, SERCA has been
regarded as a potential mediator of alterations of the ER
Ca2+-content. In heart failure, the ER Ca2+-content of car-
diac myocytes has been found to be reduced due to altered
expression of SERCA [6]. In our laboratory, bronchial
hyperreactivity in an asthma model was correlated with
increased Ca2+-content in the sarcoplasmic reticulum of
airway smooth muscle cells [4]. Further, in an interleukin
based asthma model, the increased Ca2+-content was at
least partially caused by increased expression of SERCA
[7]. Several studies investigated the expression of SERCA
in normal and tumor tissue reporting downregulation of
SERCA were inhibited using 1 μM cyclopiazonic acid leading  to a net Ca2+-efflux out of the ER Figure 3
SERCA were inhibited using 1 μM cyclopiazonic acid 
leading to a net Ca2+-efflux out of the ER. The resulting 
increase in [Ca2+]c was used as an estimate of the [Ca2+]ER 
and expressed as percentage of NHBE. (A) In EPLC and 
LCLC cells in which Ca2+-influx contributed to the ATP-
induced Ca2+-increase the [Ca2+]ER was equal to the [Ca2+]ER 
of NHBE. (B) In H1339 and HCC cells in which the Ca2+-
influx did not contribute to the ATP-induced Ca2+-increase 
the ER Ca2+-content was lower than in NHBE cells (n = 50 – 
153 cells, * = P < 0.001 versus all other groups).
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Immunohistochemical staining of SERCA 2 in a H1339 cell Figure 4
Immunohistochemical staining of SERCA 2 in a 
H1339 cell. Note the ER-typical pattern of the staining as 
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this ATPase in cancer [8-11]. But, in colorectal cancer,
Chung et al. reported that SERCA 2 mRNA was increased
compared to normal tissue [12]. Moreover, increased
SERCA 2 protein levels were correlated with serosal inva-
sion, lymph node metastasis, advanced tumor stage and
poorer survival-rate. Hence, an altered Ca2+-content of the
ER might not only be involved in the early steps of car-
cinogenesis but may also cause further malignant trans-
formation towards an invasive and aggressive phenotype.
Investigating the correlation of SERCA expression,
[Ca2+]ER and proliferation, Legrand et al. showed that in
prostate cancer cells an increased growth rate was corre-
lated with higher [Ca2+]ER and increased SERCA 2 expres-
sion [13]. A decreased growth rate was correlated with
decreased [Ca2+]ER and decreased expression of SERCA 2b.
Neuroendocrine differentiation of prostate cancer cells is
considered to mark increased aggressiveness of cancer
growth. Vanverberghe et al. showed that neuroendocrine
differentiation in these cells was associated with apoptosis
resistance probably due to decreased filling of the ER
Ca2+-store caused by under-expression of SERCA 2 and
calreticulin [14]. But, Crepin at al. reported that prolactin
stimulated proliferation in immortalized prostate cells
through increased [Ca2+]ER due to increased SERCA 2
expression [15]. In a comprehensive review, Lipskaia pro-
posed that proliferation is associated with a sustained
increase in [Ca2+]c  or sustained Ca2+-oscillations,
decreased refilling of the ER because of SERCA inhibition,
and enhanced store operated Ca2+-entry from the extracel-
lular space [16]. Apparently, the relationship between
[Ca2+]ER, SERCA expression and tumor growth varies
between studies, cell types and differentiation status.
However, an altered ER Ca2+-homeostasis is obviously
involved in malignant transformation. To our knowledge,
this is the first report showing an altered ER Ca2+-homeos-
tasis in lung cancer cells.
The IP3R is a Ca2+-channel composed of 4 subunits, which
releases calcium upon the binding of IP3 [17]. Sakakura
and colleagues showed that the IP3R was overexpressed in
a gastric cancer cell line established from peritoneal dis-
semination, but weakly expressed in a gastric cancer cell
The expression of SERCA 2 was analyzed in NHBE, H1339,  and HCC cells using Western Blot analysis and expressed as  percentage of the SERCA 2 expression in NHBE cells Figure 5
The expression of SERCA 2 was analyzed in NHBE, 
H1339, and HCC cells using Western Blot analysis 
and expressed as percentage of the SERCA 2 expres-
sion in NHBE cells. In H1339 and HCC cells, the expres-
sion of SERCA 2 was found to be reduced with H1339 
showing the weakest expression (n = 3, * = P < 0.01 versus 
all other groups).
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The expression of IP3R was analyzed in NHBE, H1339, and  HCC cells using Western Blot analysis and expressed as per- centage of the IP3R expression in NHBE cells Figure 6
The expression of IP3R was analyzed in NHBE, 
H1339, and HCC cells using Western Blot analysis 
and expressed as percentage of the IP3R expression 
in NHBE cells. In H1339 and HCC cells, the expression of 
IP3R was increased with H1339 showing the highest expres-
sion (n = 4, * = P < 0.01 versus all other groups).
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line established from a primary tumor as well as in nor-
mal gastric epithelial cells [18]. The authors therefore sug-
gest a role for the IP3R in the transition to a metastatic
phenotype. Our finding of increased IP3R expression in
H1339 and HCC cells is in agreement with in vivo data
obtained from patients with resectable NSCLC, where
Heighway et al. found amplification of the IP3R gene in
the tumor tissue compared to normal tissue [19].
Calreticulin is a 46-kDa chaperone that binds calcium in
the lumen of the ER with high capacity [20]. It also partic-
ipates in the folding of newly synthesized proteins.
Recently, a role for calreticulin in immunogenic cell death
has been proposed [21]. The authors reported that anthra-
cyclines and γ-irradiation induced translocation of calreti-
culin to the plasma membrane thereby stimulating
immunogenic cell death. In this context, our finding of
reduced calreticulin expression in lung cancer cells could
be of particular importance.
A decreased [Ca2+]ER is regarded as a pathophysiological
mechanism in heart failure [6]. Istaroxime is a SERCA acti-
vator that has been successfully tested in a clinical phase
1–2 trial and found to be well tolerated and to improve
cardiac function [22]. As substances altering the intracel-
lular Ca2+-homeostasis become available for clinical use,
the altered Ca2+-homeostasis of cancer cells may become
a valuable target to improve therapeutic options in lung
cancer.
Conclusion
In our study, we showed that in H1339 and HCC cells the
ER Ca2+-content was reduced compared to NHBE cells.
The reduced Ca2+-content correlated with a reduced
expression of SERCA 2 pumping calcium into the ER, an
increased expression of IP3R releasing calcium from the
ER, and a reduced expression of calreticulin buffering cal-
cium within the ER. The differences in the intracellular
Ca2+-homeostasis between lung cancer and normal bron-
chial epithelial cells may lay the basis for new diagnostic
or therapeutical approaches.
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The expression of calreticulin was analyzed in NHBE, H1339,  and HCC cells using Western Blot analysis and expressed as  percentage of the calreticulin expression in NHBE cells Figure 7
The expression of calreticulin was analyzed in NHBE, 
H1339, and HCC cells using Western Blot analysis 
and expressed as percentage of the calreticulin 
expression in NHBE cells. In H1339 and HCC cells, the 
expression of calreticulin was reduced with HCC cells show-
ing the weakest expression (n = 3, * = P < 0.01 versus all 
other groups).
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Cells were treated with 1 μM CPA for 24 h to inhibit SERCA Figure 8
Cells were treated with 1 μM CPA for 24 h to inhibit 
SERCA. The cell number was assessed after 24 h and 
expressed as percent of the non-treated controls. In NHBE 
cells, non-small cell lung cancer cells (HCC and EPLC M1), 
and small cell lung cancer cells (H1339 and DMI 53 pI) the 
cell number was higher after CPA treatment.
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